Industries > Pharma > Amniotic Membrane Market Report 2019-2029

Amniotic Membrane Market Report 2019-2029

By End Use (ASC, Hospital), by Enzyme (Dehydrated, Cryopreserved), by Application (Ophthalmology, Surgical Wounds), Region and Segment Forecasts

PAGES: 169

WOOCS 2.2.1
SKU: PHA0503 Categories: , Tag:

Amniotic membrane is the innermost layer of the placenta which has medication and anti-scarring properties. Due to its virtue amniotic membrane is used in cosmetic surgeries, ophthalmic surgeries. It protects surfaces from microbial colonization minimising the risk of infections besides having the presence of growth factors like Fibroblast Growth Factor (bFGF), Transforming Growth Factors (TGFs), Epidermal Growth Factor (EGF), Vascular Endothelial Growth Factor (VEGF), Nerve Growth Factor (NGF), and Keratinocyte Growth Factor (KGF) which promotes wound healing.

Market Overview and Trends
Cryopreservation is expected to be the major segment of this market which help maintain histological and biological properties of the sample. Surgical wounds segment will also witness increase growth in this sector as the demand surges.

With respect to geographical breakdown, North America will contribute to the major share of the market due to presence of a large number of key companies and high incidence of chronic and infectious diseases. The Asia-Pacific region will witness the highest growth in this market segment due to growing population and rising incidence of chronic diseases and burn injuries.

Factors Influencing the Market Growth:
• Rise in trauma, burn cases and resulting surgeries which creates the demand
• Rise in awareness regarding the benefits of these products
• Increase in the number of cosmetic surgeries performed in the forecasted period
• Rise in technological advancement

Factors Restraining the Market Growth:
• Lack of skilled/experienced professionals to perform Amniotic membrane transplantation
• Lack of standardized guidelines on tissue and bio-medical engineering

Market Segmentation 2019-2029:
The Amniotic Membrane market is segmented By End Use (ASC, Hospital), By Enzyme (Dehydrated, Cryopreserved), By Application (Ophthalmology, Surgical Wounds), Region and Segment Forecasts

Market Segmentation Covered:
• Global Amniotic Membrane Enzymes Market 2019-2029
– Global Cryopreserved Amniotic Membrane Market 2019-2029
– Global Dehydrated Amniotic Membrane Market 2019-2029
• Global Amniotic Membrane Application Market 2019-2029
– Global Surgical Wounds Market 2019-2029
– Global Ophthalmology Market 2019-2029
– Global Others Market 2019-2029
• Global Amniotic Membrane End Use Market 2019-2029
– Global Hospitals Market 2019-2029
– Global Ambulatory Surgical Centers Market 2019-2029
– Global Specialty Clinics Market 2019-2029
– Global Research Institutes and Academic Institutes Market 2019-2029

Geographic Breakdown
Focused regional forecasts and analysis explore the future opportunities:
• North America Market, 2019-2029
• Europe Market, 2019-2029
• Asia-Pacific Market, 2019-2029
• LAMEA Market, 2019-2029

Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the Amniotic Membrane market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.

Major Market Players:
Alliqua BioMedical, Inc.; Amnio Technology, LLC; Applied Biologics LLC; Human Regenerative Technologies, LLC; DermaSciences; Katena Products, Inc.; MiMedx Group, Inc.; Skye Biologics, Inc.; Amniox Medical, Inc.; and Organogensis, Inc.

Key questions answered by this report:
• What is the current size of the total global Amniotic Membrane market?
• How much will this market be worth from 2018 to 2029?
• How is the Amniotic Membrane market evolving?
• What is driving and restraining the Amniotic Membrane market?
• What are the market shares of each segment of the overall Amniotic Membrane market currently and how will these change to 2029?
• What are the main submarkets and how much revenue will each Amniotic Membrane market submarket account for over the next 10 years to 2029 and why?
• How will the market shares for each Amniotic Membrane market submarket develop from 2018 to 2029?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve to 2029?
• What are the largest national markets for Amniotic Membrane market? What is the current status and how will it develop over the next ten years? What are their forecasts for 2019-2029?
• Who are the most prominent companies, and what are their activities and outlooks?
• What are the main trends that will affect the Amniotic Membrane market between 2018 and 2029?

Visiongain’s study is intended for anyone requiring commercial analyses for the Amniotic Membrane market. You find data, trends and predictions.

Buy our report today Amniotic Membrane Market Analysis : By End Use (ASC, Hospital), By Enzyme (Dehydrated, Cryopreserved), By Application (Ophthalmology, Surgical Wounds), Region and Segment Forecasts

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help:

Download sample pages

Complete the form below to download your free sample pages for Amniotic Membrane Market Report 2019-2029

Download sample pages

Complete the form below to download your free sample pages for Amniotic Membrane Market Report 2019-2029

Latest Pharma news

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021


Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021


Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021


Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021